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Highlights: 
• Specific human Hsp70 chaperone system efficiently disassembles α-
synuclein fibrils. 
• Fragmentation and depolymerisation generate short fibrils and non-toxic 
monomers. 
• Coordinated chaperone binding cycles generate power stroke for 
disassembly. 
• Fibril disassembly requires N- and C-terminal α-synuclein extensions.  
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Abstract  
 
Intracellular amyloid fibrils linked to neurodegenerative disease 
typically accumulate in an age-dependent process, suggesting an inherent 
cellular capacity for counteracting amyloid formation in early life. Molecular 
chaperones assist native folding and block polymerization of amyloidogenic 
proteins, preempting amyloid fibril formation. The capacity of metazoan 
chaperones for amyloid disassembly, however, is unclear. Here, we show a 
specific combination of human Hsp70 chaperone components efficiently 
disassembles α-synuclein amyloid fibrils, characteristic of Parkinson’s 
disease, in vitro. Specifically, the Hsc70 chaperone, the class B J-protein 
DNAJB1 and an Hsp110-family nucleotide exchange factor (NEF) provide an 
ATP-dependent activity that disassembles amyloids within minutes via 
combined fibril fragmentation and depolymerisation, ultimately generating 
non-toxic α-synuclein monomers. Concerted, rapid interaction cycles of all 
three chaperone components with fibrils generate the power stroke required 
for disassembly. This identifies a powerful human Hsp70 disaggregase 
activity that efficiently disassembles amyloid fibrils and a mammalian protein 
quality control pathway crucial to the biology of amyloid-based 
neurodegenerative diseases. 
 
Introduction 
 
Many neurodegenerative diseases are characterized by the misfolding 
and oligomerisation of specific proteins, leading to amyloid-type fibril 
formation. Examples include α-synuclein (α-Syn) in Parkinson’s disease, β-
amyloid (Aβ) and Tau in Alzheimer's disease and tauopathies, superoxide 
dismutase (SOD1) in amyotrophic lateral sclerosis and polyglutamine-
expanded huntingtin in Huntington’s disease (Knowles et al., 2014). Typically, 
these diseases are of late-onset, but the factors determining oligomerisation 
and fibril formation in cells are poorly defined. Even in mutation-driven 
manifestations, the toxicity-generating protein remains latent for years, often 
decades, before clinical or microscopic symptoms are detectable (Blennow et 
al., 2006). Increasing evidence pinpoints oligomeric, shorter forms as the 
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more neurotoxic conformers of amyloidogenic proteins, but amyloid fibrils can 
also exhibit cell toxicity (Bieschke et al., 2010; Caughey and Lansbury, 2003; 
Dedmon et al., 2005; Pieri et al., 2012). 
Oligomerisation and fibril formation depend on rate-limiting 
conformational alterations of the amyloidogenic proteins and generation of 
fibril-nucleating oligomers (Jarrett and Lansbury, 1993; Lomakin et al., 1996), 
and are counteracted by cellular protein quality surveillance activities. In 
quality control, molecular chaperones recognize misfolded proteins and 
respond either by targeting them for degradation (Kim et al., 2013) or, via 
“holdase” function, stabilizing folding intermediates to favor refolding to the 
native state, preempting fibril formation. A range of different metazoan 
chaperones and co-chaperones including Hsp70, J-domain proteins (J-
proteins), Hsp110 and small HSPs associate with α-Syn and other 
amyloidogenic proteins in various oligomeric states (Cantuti-Castelvetri et al., 
2005; Chen et al., 2011; Wang et al., 2009). These are known to suppress 
amyloid fibril formation both in vivo (Kieran et al., 2004; Takeuchi et al., 2002) 
and in vitro (Dedmon et al., 2005; Evans et al., 2006; Huang et al., 2006; Lee 
et al., 2005; Muchowski and Wacker, 2005) via holdase function. Whether 
metazoan chaperones can directly disintegrate already existing fibrils 
however, is less clear. Chaperone-mediated amyloid disassembly would 
immediately impact pathophysiology, by affecting levels of amyloids and 
oligomeric species linked to cell toxicity. 
In yeast cells, fibrils are fragmented by the powerful bi-chaperone 
system consisting of the AAA+ Hsp100 disaggregase and the Hsp70 
chaperone and its J-protein co-chaperone (Helsen and Glover, 2012; 
Higurashi et al., 2008; Reidy et al., 2012; Shorter and Lindquist, 2004; Tuite et 
al., 2011; Winkler et al., 2012). Metazoans, however, entirely lack the Hsp100 
family disaggregases in the cytosol and nucleus, and efficient in vitro 
disassembly of metazoan amyloid aggregates on a physiologically relevant 
time scale (minutes to hours), has so far not been demonstrated (Bieschke et 
al., 2009; Duennwald et al., 2012; Evans et al., 2006; Murray et al., 2013; 
Murray et al., 2010). Metazoans do nonetheless solubilize amorphous, stress-
induced protein aggregates, both in vivo and in vitro. Disaggregation of 
amorphous aggregates, which are considered to be energetically less stable 
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than amyloid fibrils, is provided by Hsp70 chaperones together with co-
chaperones of the J-protein family and Hsp110 nucleotide exchange factors 
(NEFs) (Rampelt et al., 2012; Shorter, 2011). J-proteins bind substrates and 
stimulate ATP hydrolysis by Hsp70, which traps substrates in complex with 
Hsp70. NEFs then stimulate ADP release enabling rebinding of ATP to Hsp70 
with concomitant substrate release (Bukau and Horwich, 1998). However, 
when tested for its ability to disassemble amyloids in vitro, the human Hsp70 
machinery disassembled α-Syn amyloids only extremely slowly, at a time 
scale of weeks (Duennwald et al., 2012). The efficacy, and hence 
pathophysiological relevance, of cellular amyloid disaggregation activity 
therefore remains a largely unsolved issue.  
We therefore investigated in detail the potential of the human Hsp70 
network for α-Syn amyloid disassembly. Here, we examine the interaction of a 
variety of constituents of the Hsp70 machinery with α-Syn amyloid fibrils 
preformed in vitro. We find that the constitutively expressed Hsc70 (HSPA8), 
the class B J-protein DNAJB1, and the Hsp110-family NEFs Apg2 or Hsp105, 
form a specific, surprisingly powerful ATP-driven metazoan disaggregase for 
amyloids, that efficiently disassembles α-Syn fibrils in vitro. The disaggregase 
activity fragments α-Syn fibrils into increasingly shorter fibrils and promotes 
depolymerisation into non-toxic α-Syn monomers within minutes. We directly 
visualize and dissect the kinetics of chaperone association with α-Syn fibrils 
and fibril disintegration by electron microscopy (EM) combined with 
biochemical and fluorescence techniques. Our findings provide the basis for a 
model of chaperone function in amyloid fibril disassembly.  
 
 
Results 
 
A human Hsp70 disaggregase solubilizes α-Syn fibrils in vitro 
We initially tested several different major components of the human 
cytosolic Hsp70 chaperone system, individually and in combination, for α-Syn 
fibril disassembly activity. For disassembly assays we used established 
Hsp70-based protein disaggregation reaction conditions (Dragovic et al., 2006; 
Rampelt et al., 2012; Tzankov et al., 2008) and a homogeneous substrate of 
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preformed α-Syn amyloid fibrils, verified by negative stain transmission EM 
(Figure 1A). We analyzed solubilized reaction products, separated by 
centrifugation and identified by SDS-PAGE and immunoblotting with an α-
Syn-specific antibody. Individually, the constitutively expressed chaperone 
Hsc70 (HSPA8), the heat-inducible chaperone Hsp70 (HSPA1A), the J-
protein co-chaperones of classes A (Hdj2; DNAJA1) and B (Hdj1; DNAJB1), 
and the Hsp110-family NEF Apg2 (HSPA4; HSPH2) are unable to solubilize 
α-Syn from preformed fibrils. Hsc70 in combination with DNAJB1 solubilizes 
only a small fraction of the α-syn fibril material (Figure 1B). However, with the 
addition of either Hsp110-family NEF Apg2 or Hsp105α into the reaction 
containing Hsc70 and DNAJB1, solubilization increases dramatically in an 
ATP-dependent manner (Figures 1B and S1A). An alternative, Bag family 
type NEF (Bag1), is only about 20% as efficient (Figure S1A), which 
demonstrates high selectivity for the effective NEF. Under these conditions, 
DNAJB1-Agp2 combinations containing Hsc70 solubilize fibrils to greater 
extent than combinations containing stress-inducible Hsp70 (Figure S1A). 
Also, the Hsc70-Agp2 combination showed activity only in combination with 
class B J-protein DNAJB1 and not with class A DNAJA1 (Figure S1A).  We 
infer the Hsc70–DNAJB1-Hsp110 machinery has highly efficient 
disaggregation activity on α-Syn fibrils. This basic combination of chaperones 
is therefore used for all further experiments, unless otherwise indicated. 
 
Complete fibril solubilization occurs with fast kinetics 
A ratio of chaperones (Hsc70/DNAJB1/Apg2) to α-Syn of 1:1 (Hsc70:α-
Syn monomer) converts 50% of fibrillar α-Syn (at 2 µM α-Syn monomer 
concentration) to soluble material within 8 h (Figure 1C). Higher relative 
amounts of the machinery compared to fibrils (Hsc70:α-Syn of 2:1 and 5:1), 
with Hsc70:DNAJB1:Apg2 stoichiometries kept constant at 1:0.5:0.1, work 
dramatically faster. At 5:1 Hsc70:α-Syn ratio, the chaperone combination 
converts 50% of α-Syn fibrils to soluble form within 40 min (Figure 1C). Yields 
of solubilized fibrils are maximally 70-80% of total α-Syn, at all ratios tested. 
This maximum may be due to exhaustion of the chaperone machinery during 
the 24 h incubation time (e.g. by chaperone aggregation, drop in ATP levels, 
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absorption to the test tube). This is supported by experiments described 
below, where successive addition of chaperones allows for continued fibril 
disassembly (Figure S3B). We infer that the human Hsc70 chaperone-co-
chaperone system can, in principle, solubilize α-Syn amyloid fibrils to 
completion. Further, the in vitro reaction occurs within minutes at 30°C, 
implying that under the physiological temperature for human cells (37°C) 
disassembly is likely to be at least as efficient. The concentration of Hsc70 
monomers in human cells is around 10 µM (Nollen et al., 2000), and 
estimated to be 2500-fold higher than that of α-Syn monomers in various 
human cell types (Finka and Goloubinoff, 2013). This suggests the 
concentrations required for efficient fibril disassembly in vitro are in principle 
attainable in cells. For instance at the 1:1 Hsc70:α-Syn ratio used in our 
assays, the Hsc70 concentration is 2 µM, which is well within the 
physiological concentration range.  
We then examined the α-Syn species solubilized after 4 h incubation 
with Hsc70/DNAJB1/Apg2. We distinguished monomeric α-Syn from small 
oligomeric products using a fluorescence assay. We formed fibrils from a 
cysteine variant of α-Syn (α-Syn-S9C) that have indistinguishable morphology 
by EM from fibrils formed of wild-type α-Syn (Figure S1B). Labeling of the 
fibrils with the thiol-specific fluorescent dye Alexa488-maleimide (Alexa488-α-
Syn) allows sensitive fluorescence detection of solubilized species by gel 
filtration. Most soluble material (>80%) eluted with monomeric α-Syn (Figures 
1D and 1E). Since the dye fluorescence is quenched by incorporation into the 
α-Syn fibrils (Graf et al., 2009; Kityk et al., 2012), we also followed fibril 
disassembly by fluorescence dequenching in real time (Figure S1C). 
Dequenching depends strictly on the presence of Hsc70/DNAJB1 and ATP, 
and is greatly accelerated by Apg2. The addition of Bag1 instead of Apg2 
leads to much less dequenching (approx. 80% less). We conclude specific 
compositions of the human Hsc70 chaperone system constitute a powerful 
ATP-driven disaggregase capable of extensively solubilizing α-Syn fibrils to 
monomers.  
 
The human Hsp70 system solubilizes α-Syn aggregates generated in vivo 
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To determine whether Hsc70/DNAJB1/Apg2 will also disassemble α-
Syn aggregates produced in vivo, we overexpressed human α-Syn fused to 
YFP in Caenorhabditis elegans muscle cells (van Ham et al., 2008). 
Detergent (1% Sarkosyl)-resistant α-Syn aggregates were isolated. Upon 4 h 
incubation with the human Hsc70/DNAJB1/Apg2 chaperone system and ATP, 
α-Syn-YFP shifted partially from the pellet to the supernatant fraction after 
centrifugation (Figure 1F). We infer α-Syn aggregates preformed in vivo are 
efficiently disassembled. 
 
Dual mechanism of fibril disassembly  
Two non-exclusive molecular mechanisms accommodate Hsc70-based 
α-Syn fibril disassembly. A fragmentation activity similar to that of the Hsp100 
disaggregase on yeast Sup35 and Ure2 prions (Inoue and Yoshida, 2006; 
Shorter and Lindquist, 2006) may break fibrils into shorter fragments and 
finally to monomers. Alternatively, depolymerization by dissociation of single 
α-Syn molecules from fibril ends (and perhaps internal sites of fibrils) may 
also drive solubilization of fibrils to monomers. We employed three 
approaches to investigate these two mechanisms. 
In a first approach we estimated the lengths of 600 chaperone-treated 
and untreated α-Syn fibrils from 64 randomly chosen representative EM 
pictures per reaction time point (Figure S2A shows representative EM 
pictures). Depolymerization alone might be expected to decrease length at a 
similar rate in all fibrils, accompanied by corresponding increase in soluble 
monomeric α-Syn. The average mature fibril length was approximately 1000 
nm (Figure 2A). In control reactions lacking chaperones, fibril length 
distribution did not change over time. In the presence of Hsc70/DNAJB1/Apg2 
and ATP, the longer fibrils (>500 nm length) decreased rapidly in number, the 
longest fibrils (>2000 nm) disappearing even within 2 min (Figures 2A and 
S2A). In contrast, short fibrils (<500 nm) increased in abundance over the 
entire 24 h incubation time, which is incompatible with a depolymerisation-
only mechanism. Furthermore, fibril shortening by depolymerization alone 
would require a very high initial depolymerization rate during the noticeably 
fast first 2 min of reaction, and would result in substantial solubilized 
monomeric material. We did not see this (Figure 1C, inset). We infer 
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fragmentation, rather than depolymerization, contributes most significantly to 
initial fibril shortening. 
A second approach directly detects fibril fragmentation. We used 
preformed α-Syn fibrils capped with biotinylated Avi-tagged α-Syn (Beckett et 
al., 1999). This allows fibrils to bind streptavidin-coated magnetic beads 
(Figure 2B), which enables magnetic separation from released material after 
incubation with chaperones, a method successfully used for yeast prions 
(Inoue and Yoshida, 2006). Analyses by SDS-PAGE, native PAGE and EM 
show ATP and chaperone dependent release of wild-type α-Syn, but not 
biotinylated Avi-tagged α-Syn from the capped fibrils (Figure 2C). After 2 h of 
treatment with the complete chaperone system about 20% of bound α-Syn 
was released (Figures 2C and S2B). Three cycles of newly added chaperones 
released additional α-Syn, to a total of 60% of input (Figure S2C). Native 
PAGE reveals a mixture of monomeric and oligomeric α-Syn species in the 
released material (Figure S2D). EM images of this released material show 
short fibrils with a significantly shorter average length than that of untreated 
capped α-Syn fibrils. We infer that chaperone action promotes fibril 
depolymerisation as well as fragmentation (Figure 2D).  
A third approach further characterizes fibril disassembly by 
fractionating reaction products using density gradient centrifugation (Figure 
3A). Monomeric α-Syn appears prominently in fractions 1-4; mature fibrils 
pellet in fraction 25. After 2 min incubation with Hsc70/DNAJB1/Apg2 and 
ATP, α-Syn was detected in fractions 1-4, 10-19, and 25 but not in fractions 5-
9 and 20-24. EM images show quantity of fibrils peaking in fractions 10-19. 
These are on average shorter than fibrils in fraction 25 (Figure 3B). Control 
reactions with incomplete chaperone combinations detect α-Syn mainly in 
fraction 25 that is, in intact fibril form (Figure S3A). Efficient fibril shortening 
therefore requires the full chaperone system. We further infer that mature 
fibrils do not shorten gradually but are cut into shorter fragments of 
intermediate length. With increasing incubation time, the amount of mature α-
Syn fibrils in fraction 25 decreases rapidly. In contrast, amounts of shortened 
fibrils from intermediate fractions (10-19 pool II) initially (after 30 min reaction) 
increased, but then (after 2 h) decreased. The position of peak fractions of 
shortened fibril does not shift during the incubation time (Figure S3B). 
	   9	  
However, the amounts of α-Syn in fractions 1-4 (pool I) increased 
continuously and most dramatically after 2 h (Figure 3C). This suggests rapid 
conversion of short fibrils to monomers as the reaction proceeds. The 
increase of monomeric α-Syn is non-linear on a logarithmic timescale (Figure 
3C) and correlates with the gradual increase in number of fibril ends over time. 
We do not detect α-Syn in fractions 5 to 9 by immunoblot analysis, suggesting 
that disassembly of the short fibrils is very rapid, and may involve an efficient 
depolymerisation mechanism. 
A disaggregation mechanism involving depolymerisation is further 
supported by quantitative assessment of the experimental data. After 50 min 
of reaction, approximately 50% of the total input of α-Syn protomers is 
converted to intermediate fibrils (middle fractions 10-19) and 25% appears in 
monomer fractions (Figure 3C). Based on the average length of the short 
fibrils (254 nm) and the protomer arrangement in the structural model of α-
Syn fibrils (Vilar et al., 2008) (see Experimental procedures for details) we 
estimate that short fibrils consist of, on average, 2000 α-Syn protomers. The 
molar ratio of short fibrils to monomers is thus approximately 1:1000 
(0.5/2000:0.25/1) after 50 min of reaction. Monomeric α-Syn therefore, cannot 
be the sole immediate byproduct of the fragmentation action of 
Hsc70/DNAJB1/Apg2. We infer from this high ratio of monomer to fragment 
that most monomeric α-Syn is produced by end-depolymerization. 
 
EM analysis of fibril disintegration  
We investigated the molecular features of the fibril disintegration 
process by electron microscopy. Inspection of fractionated reaction samples 
containing shortened fibrils (fraction 15) by negative stain EM shows these 
are frequently coated with large and amorphous globular structures (Figure 
3D) exceeding the size observed for chaperones associated with fibrils. These 
structures probably represent small α-Syn oligomers originally disassembled 
from mature fibrils. In many images short fibrils appear aligned (Figures 3D 
and S3E). This is not seen in untreated samples, nor in samples incubated 
with an incomplete complement of chaperone machinery (Figure S3E). We 
surmise the short fibril alignment results from the severing action of 
Hsc70/DNAJB1/Apg2 progressively introducing nicks in fibrils and 
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protofilaments of the fibrils, rendering the fibril structure susceptible to 
breakage during staining on the grid. 
Examining sections through reconstructed volumes of fibrils from 
sucrose gradient fractions 25 (Figure 4) or 16 by electron tomography reveals 
further details of fibril structure and chaperone-induced fibril disintegration 
(Figure 4B). Untreated fibrils appear smooth, revealing their substructure 
composed of four protofilaments (Vilar et al., 2008) (Figure 4A). After 
incubation with Hsc70/DNAJB1/Apg2 and ATP, however, globular complexes 
of variable sizes are seen bound to fibril surfaces (Figure 4C and movie S1), 
as described after negative stain EM (Figure 3D). At sites of fibril breakage we 
frequently observe fragments consisting of protofibrils or nicked chunks of 
protofibrils aligned on the grids (Figure 4D and movie S1). These protofibrils 
are thinner (8-12 nm in diameter) than chaperone-decorated mature twisted 
fibrils (15-25 nm in diameter, dependent on the twist). Protofibrils appear to be 
unstable and prone to bind to each other. 
Overall our EM analyses suggest that the Hsc70/DNAJB1/Apg2 
chaperone combination introduces internal nicks into protofilaments, thereby 
weakening the fibril structure and generating short protofibril fragments that 
can dissociate from the fibrils. 
 
Chaperone association to α-Syn fibrils 
To obtain molecular insight into the mode of action of 
Hsc70/DNAJB1/Apg2 we investigated which chaperone components bind to 
α-Syn fibrils. Upon sucrose gradient centrifugation in the absence of fibrils, 
chaperones float to the top of the sucrose gradient, reflecting monomeric or 
indistiguishable very small oligomeric forms (Figure S3C). After incubation of 
the chaperones with α-Syn fibrils however, individually or in combination, 
Hsc70 and DNAJB1 are also detected by immunoblotting in fractions 10-19 
and 25, as are fibrils. This implies binding of these proteins to fibrils (Figure 
3A). The NEF Apg2, when added alone to the fibrils, was detected by 
immunoblotting only in fraction 25 (Figure 3A, lower panel). When added with 
DNAJB1 and Hsc70, Apg2 was also present in the shortened fibril fractions 
10-19, but at markedly lower levels than the other two chaperones, and was 
detectable by mass spectrometry (Figure S3D). Binding of all three 
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chaperones (Hsc70, DNAJB1, Apg2) to shortened α-Syn fibrils treated with 
the complete chaperone combination was further corroborated by 
immunogold labeling (Figure 3E).  
To determine the structural contributions of the individual components 
to the active multicomponent machinery, we reconstructed EM-tomograms of 
fibrils separately treated with Hsc70, DNAJB1 or Apg2, or with the 
Hsc70/DNAJB1 combination (Figure 4E). Analysis of the reconstructed 
volumes reveals that each chaperone contributes a distinctive structural 
signature to the complexes. Hsc70 on its own results in an irregular coating of 
fine and coarse features (2-5 nm in diameter). DNAJB1 alone coats the fibrils 
with a uniform layer of about 2-3 nm features with a spacing of about 5 nm 
along the fibril surface. A sparser decoration is seen for Apg2, with complexes 
ranging between 5-10 nm in diameter. Hsc70 and DNAJB1 added together 
result in a combination of their individual features and the fibril surface has a 
more rough appearance not seen in the individual treatments, which may be 
due to formation of Hsc70-DnaJB1 complexes or alterations in the fibril 
structure. These observations confirm that all three chaperones are capable 
of independently binding to α-Syn fibrils, but also suggest that DNAJB1 binds 
most efficiently, fully and uniformly coating the surface, consistent with its 
established role in substrate recruitment. 
 
Kinetics of chaperone interaction with α-Syn fibrils 
For dissection of the fibril disassembly mechanism, we quantified the 
interaction of chaperones and α-Syn fibrils using fluorescence techniques 
(Figure 5). The binding constants of DNAJB1-fibril and Hsc70-fibril 
interactions were analyzed by fluorescence anisotropy, which measures 
changes in rotational diffusion of the fluorescent molecules upon interaction, 
using Alexa488-labeled DNAJB1-G194C (Alexa488-DNAJB1) and Hsc70-
T111C,C267A,C574A,C603A (Alexa488-Hsc70) (Figure 5A). Upon interaction 
with fibrils, the fluorescence anisotropy of the labeled chaperones changes, 
allowing to detect and quantify complex formation. Titration of labeled 
DNAJB1 or Hsc70 (with ATP) with α-Syn fibrils yielded equilibrium 
dissociation constants (KD) of 5.6 ± 0.8 µM and 3.1 ± 0.4 µM, respectively. 
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The affinity of Alexa488-Hsc70 for fibrils increased in the presence of 
DNAJB1, yielding a KD of 0.17 ± 0.02 µM. DNAJB1 therefore increases 
Hsc70’s affinity for fibrils strongly, by 18-fold.  
We then investigated the kinetics of these interactions. Alexa488-
DNAJB1 associated to α-Syn fibrils at a rate too high to be determined 
accurately in our experimental setup (Figure S4A). The dissociation of 
Alexa488-DNAJB1 from fibrils was measured by addition of an excess of 
unlabeled DNAJB1 to the Alexa488-DNAJB1-α-Syn fibrils, which prevents 
Alexa488-DNAJB1 rebinding to fibrils after it had dissociated. Addition of 
unlabeled DNAJB1 results in a decrease of anisotropy (Figure S4B), 
corresponding to a dissociation rate (koff) of 0.0185±0.001 s-1. Based on the 
measured equilibrium KD and koff, the calculated rate for Alexa488-DNAJB1 
association (kon) to fibrils is 3303 M-1s-1. The association kinetics for 
Alexa488-Hsc70 were determined at various concentrations of α-Syn fibrils 
(based on the monomer concentration) and all data globally fitted using a 
second order rate equation (Figures S4D and S4E; Table S1) (Rutkowska et 
al., 2008). The association of Alexa488-Hsc70 to fibrils in the presence of 
ATP (123±38  M-1s-1; Figure S4D) is about 30-fold slower than the calculated 
kon for Alexa488-DNAJB1 but is 20-fold accelerated with DNAJB1 present 
(2539±57  M-1s-1; Figure S4E and Table S1). Disrupting the J-protein HPD 
motif, which is essential for interaction with Hsp70 (Tsai and Douglas, 1996), 
by mutation to QPN abrogates acceleration of the kon (Figure S4C). We infer 
DNAJB1 stimulation of the Hsc70 ATPase activity is required for efficient 
Hsc70 association to α-Syn fibrils.  
The presence of DNAJB1 increases the kon of Alexa488-Hsc70 to fibrils 
by 20-fold, but increases the koff by only 2.6-fold. The KD of the Alexa488-
Hsc70-fibril complex in the presence of DNAJB1 determined directly by 
equilibrium titration (0.17 µM) is however, 10-fold lower than the KD calculated 
from kon and koff values (1.7 µM). This discrepancy may be explained by the 
existence of biphasic association and dissociation kinetics, similar to those 
shown for the substrate binding kinetics of other Hsp70s (Pierpaoli et al., 
1998), which we cannot resolve in our measurements and precludes precise 
calculation of KD values based on kon and koff values. Despite this limitation, 
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our results unequivocally show that DNAJB1 acts by accelerating the 
association of Hsc70 with fibrils in the presence of ATP. 
We then investigated any effects of NEFs on the release of DNAJB1 
and Hsc70 from fibrils. To measure DNAJB1 release we used Alexa594-
DNAJB1 (acceptor) and preformed Alexa-488-α-Syn fibrils (donor) in Förster 
resonance energy transfer (FRET) assays. This allows specific monitoring of 
interactions between DNAJB1 and α-Syn fibrils in the presence of Hsc70, and 
avoids background fluorescence anisotropy signals generated from the 
interaction between Hsc70 and DNAJB1. Addition of Alexa594-DNAJB1 to a 
population of homogeneous Alexa-488-α-Syn fibrils increased acceptor 
fluorescence, indicative of interaction (Figures 5B and 5C). In contrast, mixing 
Alexa594-DNAJB1 and Alexa-488-labeled monomeric α-Syn did not (Figure 
S4F). DNAJB1 therefore interacts with fibrils but not with monomeric α-Syn-
S9C. Addition of Hsc70 without ATP leaves acceptor fluorescence unchanged 
(Figure 5B and C). However, including ATP drops acceptor fluorescence to 
levels between those of free and fibril bound Alexa594-DNAJB1. This 
suggests ATP binding/hydrolysis by Hsc70, or the subsequent Hsc70 binding 
to α-Syn fibrils, increases the distance between Alexa594-DNAJB1 and α-Syn 
fibrils. Interestingly, further addition of the NEF Apg2 (Figures 5B and S4G) 
reduces acceptor fluorescence to similar levels as unbound DNAJB1, though 
only when Hsc70 is present. We conclude that the interaction of Apg2 with 
Hsc70 dissociates DNAJB1 from α-Syn fibrils. 
To measure Hsc70 release, we monitored effects of Apg2 on the koff of 
Alexa488-Hsc70 from α-Syn fibrils, using anisotropy measurements. Addition 
of Apg2 to Alexa488-Hsc70-fibril complexes formed in the presence of 
DNAJB1 led to a very rapid decrease in anisotropy, which precluded 
determination of the rate of dissociation (Figures 5D and S4H). This decrease 
in anisotropy reflects rapid dissociation of Alexa488-Hsc70 from the fibrils. At 
low Apg2 concentrations anisotropy subsequently slowly increased again, 
suggesting that after initial dissociation from the fibrils, Alexa488-Hsc70 can 
slowly rebind and start a new chaperone binding cycle. Our data are 
consistent with a scenario in which the nucleotide exchange activity of Apg2 
accelerates ADP dissociation from Hsc70 followed by subsequent rapid 
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association of ATP with Hsc70, opening the Hsc70 substrate-binding pocket 
and triggering substrate release. 
Substituting Apg2 with the Hsp70-specific NEF Bag1, which belongs to 
a distinct protein family, results in dramatically lower rates of Alexa488-Hsc70 
dissociation from fibrils (Figure 5D). This holds even at Bag1 concentrations 
that lead to similar nucleotide exchange rates in Hsc70 as those achieved by 
Apg2 (Figure S4I). This difference in efficiency of Hsc70 release from fibrils 
correlates with strongly differing activities of Apg2 and Bag1 in Hsc70-
DNAJB1-mediated fibril disassembly. Apg2 accelerates efficient fibril 
disassembly while Bag1 is poorly effective at all concentrations tested (Figure 
5E). Importantly, Apg2 works optimally at substoichiometric Apg2 to Hsc70 
ratios of 1:20 to 1:10, and is even inhibitory at higher ratios such as 0.5:1 and 
1:1 (Figure S4J and S4K). We conclude that there is high specificity for NEFs 
of the Hsp110 family as cochaperones for Hsc70-mediated amyloid fibril 
disassembly. 
 
Fibril-protruding α-Syn regions are essential for disassembly 
Biophysical data implicate residues 30 to 110 of each α-Syn molecule 
in β-structure formation with neighboring α-Syn molecules to form the fibril 
core structure (Vilar et al., 2008). This leaves the N- and C-terminal regions of 
each α-Syn molecule relatively flexible and exposed in the fibril (Vilar et al., 
2008). We therefore investigated the role of these exposed regions of α-Syn 
in chaperone action during fibril disassembly.  
As previously reported (Vilar et al., 2008), we find that α-Syn30-110 
fragments form fibrils (Figure 6A). Unlike wt fibrils however, truncated α-Syn30-
110 fibrils are not disassembled by the Hsc70/DNAJB1/Apg2 machinery 
(Figure 6B). To pinpoint the critical step preventing disassembly, we 
investigated the ability of the chaperones to associate with α-Syn or α-Syn30-
110 fibrils by anisotropy (Figure 6C). Hsc70 associates with α-Syn30-110 fibrils, 
when add separately, but recruitment of Hsc70 to fibrils by DNAJB1 and 
release of Hsc70 from fibrils by Apg2 is affected in α-Syn30-110 fibrils, 
compared to wt fibrils. It is therefore possible that N- and/or C-terminal parts 
of the α-Syn molecule provide a specific binding platform for the composite 
Hsc70/DNAJB1/Apg2 machinery required for formation of the functional 
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chaperone complex. This result indicates that the N- and C-terminal regions of 
α-Syn are critical for productive chaperone targeting.  
 
Chaperone-disassembled α-Syn species are less toxic than fibrils  
For many amyloidogenic proteins including α-Syn, small, soluble 
prefibrillar oligomers are more toxic to cells than mature fibrils (Caughey and 
Lansbury, 2003; Dedmon et al., 2005; Haass and Selkoe, 2007). The 
ensemble of α-Syn oligomers interact with lipids, disrupt membranes, and kill 
cells in culture and in vivo (Caughey and Lansbury, 2003; Conway et al., 1998, 
2000; Danzer et al., 2007; Karpinar et al., 2009; Tsigelny et al., 2008; Winner 
et al., 2011). Cell toxicity has also been reported for α-Syn fibrils preformed in 
vitro and applied externally to cultured cells (Bieschke et al., 2010; Pieri et al., 
2012). A pertinent question therefore is whether fibril disassembly by the 
human Hsp70 system is beneficial or toxic for cells.  
We incubated SH-SY5Y neuroblastoma cells with either preformed α-
Syn fibrils or total or soluble fractions of chaperone-treated α-Syn fibrils. Using 
the MTT cellular viability assay we find that fibrils formed in vitro are toxic, 
whereas α-Syn monomers are not (Figure 7A). Prior incubation of fibrils with 
Hsc70/DNAJB1/Apg2 and ATP for 4 h slightly reduced toxicity of the total 
incubation mixture for neuroblastoma cells. Since these reactions contain a 
mixture of about 80% fibrils and 20% solubilized material we separated fibrils 
from disassembled soluble material by centrifugation and determined the toxic 
potential of only the disassembled material, present in the supernatant (Figure 
7A). The post-reaction soluble material was significantly less toxic when 
added externally to cells than the equivalent amount of α-Syn from a total 
disassembly reaction mixture. We conclude that monomers or very small 
soluble oligomers of α-Syn, generated from chaperone-mediated fibril 
disassembly, are less toxic than untreated fibrils. 
To further characterize the toxicity of intermediate α-Syn disassembly 
species we used a two-step purification procedure. We created Avi-tag 
capped α-Syn fibrils and treated them with the chaperone combination as 
described (Figure 2B). We separated longer/intact fibrils from disassembled 
material using streptavidin-coated magnetic beads and further fractionated 
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disassembled material by centrifugation (Figure 7B). This approach avoids the 
potential pelleting of newly generated oligomers and fragmented fibrils 
together with the original fibrils and allows further separation of fragmented 
fibrils from soluble small oligomers and monomers. In reactions without 
chaperones, no α-Syn species were liberated from the bead-tethered fibrils 
and no toxicity was observed for the total (T) and supernatant (S) of the 
material released from magnetic beads. After 4 h reaction with 
Hsc70/DNAJB1/Apg2 and ATP total α-Syn material released (T) was still toxic 
to neuroblastoma cells. Equal concentrations of the soluble supernatant (S) 
however, is much less toxic to cells than pellet material containing fibril 
fragments (P). We infer short fibrils and fragments generated by Hsc70 and 
cochaperones are not less toxic to cells. However, we find that complete 
depolymerisation of α-Syn fibrils by this chaperone system alleviates toxicity.   
 
 
Discussion 
 
This study demonstrates that the human Hsc70 chaperone together 
with DNAJB1 and Apg2 co-chaperones constitutes an unexpectedly powerful 
ATP-dependent amyloid disaggregase which in vitro, solubilizes α-Syn fibrils 
within minutes. The final products of the disassembly reaction are soluble, 
largely monomeric α-Syn species which are significantly less toxic when 
added exogenously to neuroblastoma cells than intact, or fragmented α-Syn 
amyloid fibrils. Disaggregation directly reverses the accumulation of toxic α-
Syn species and amyloid fibrils, and therefore may contribute to the 
characteristic late onset of Parkinson´s disease, and potentially even revert 
some pathophysiology. In many organisms furthermore, the capacity of the 
cellular protein quality control machinery declines during aging (Labbadia and 
Morimoto, 2015), potentially compromising  the disaggregase activity in aged 
organisms. However, our results also show that incomplete disassembly of α-
Syn fibrils by Hsc70/DNAJB1/Apg2 generates short fibrils and oligomeric α-
Syn species which are toxic and perhaps even increase amyloid seeding 
capacity in vivo. The pathophysiological manifestation of these Janus head 
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features of Hsp70-based disaggregase activity probably depends on the 
balance of cellular proteostasis.   
The existence of a powerful amyloid disassembly activity by a human 
chaperone system demonstrated here contrast earlier reports showing either 
no activity (Bieschke et al., 2009; Evans et al., 2006; Murray et al., 2013; 
Murray et al., 2010) or ony weak, up to 720-fold lower activity, requiring 30 
days incubation time with chaperones to reach 50% disassembly (Duennwald 
et al., 2012). The failure to detect a robust Hsp70-based disassembly activity 
in earlier studies probably reflects the specificity of the Hsp70 machine 
assembled. Efficient α-Syn fibril disassembly activity requires 
substoichiometric levels of the NEF relative to Hsc70 and a highly specific set 
of chaperone components. Regarding the Hsp70s, we find the heat-inducible 
Hsp70 homolog (HSPA1A) in combination with DNAJB1 and Apg2 
disassembles fibrils less efficiently than the constitutive homolog Hsc70 
(HSPA8) (Figure S1). Fibril disassembly is evidently therefore a basic 
"housekeeping" activity of the Hsp70 machinery rather than strictly dependent 
on the induction of a cellular heat stress response. Regarding the J-proteins, 
out of those family members tested, only the class B J-protein DNAJB1 
disassembles fibrils, while class A J-proteins DNAJA1 (Hdj2) (Figure S1) and 
DNAJA2 (not shown) did not. Consistent with this scenario, prion propagation 
in yeast requires the class B J-protein Sis1, but not class A J-protein Ydj1 
(Higurashi et al., 2008). Selectivity may be due to finely tuned substrate-
specific differences among J-proteins in cooperation with Hsp70. For example, 
both DNAJA1 and DNAJB1 bind to fibrils (Pemberton et al., 2011) but 
DNAJB1 is much better than DNAJA1 at promoting the loading of Hsc70 to α-
Syn fibrils (data not shown). Regarding the NEFs, members of the Hsp110 
class (Apg2 and Hsp105) strongly enhance the protein disaggregation activity 
of Hsc70/DNAJB1, but Bag-type NEF Bag1 (which lacks ATPase activity) 
does not (Figures S1 and 5E). The basis for these differences is unclear. 
Disassembly of α-Syn fibrils by Hsc70/DNAJB1/Apg2 occurs through 
ATP-dependent fragmentation (severance) and depolymerization. This dual 
mechanism generates smaller fibrils, oligomers and monomeric α-Syn, which 
we detected by (i) gel filtration of supernatant fractions of chaperone-treated 
fibrils, (ii) native gel electrophoresis of species released from biotinylated 
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fibrils, (iii) size fractionation via gradient centrifugation and (iv) EM. The main 
argument supporting a dual fragmentation-depolymerisation mechanism is the 
time course reflecting when these species are generated during the reaction. 
Fragmentation of large fibrils into significantly shorter ones occurs within a few 
minutes, well before corresponding amounts of solubilized (e.g. monomeric) 
α-Syn species appear. Depolymerisation to monomers, on the other hand, 
occurs at time points (e.g. during early and late phases of the reaction) when 
fragmentation processes alone cannot account for these products. Liberation 
of single α-Syn molecules from fibril ends is most likely energetically less 
demanding than extraction of molecules from internal sites. We therefore 
assume depolymerisation occurs predominantly at preexisting fibril ends and 
at protofilament and fibril ends newly generated by fragmentation. 
The relative contribution of depolymerisation versus fragmentation to 
the overall disassembly reaction is difficult to assess. Based on the kinetics of 
monomers and fragmented (i.e. completely physically detached) fibril 
appearance during chaperone action, we estimate generation of solubilized α-
Syn monomers via depolymerisation is approximately 1000-fold faster than 
fibril fragmentation (see results for detailed calculation). However, this 
estimate does not take into account the generation of “nicked” fibrils, during 
which individual protofilaments are severed by the action of chaperones, but 
remain attached to fibrils through the hydrophobic and electrostatic 
interactions between the four intertwined protofilaments of the mature α-Syn 
fibrils (Khurana et al., 2003). The existence of such nicked fibrils is indicated 
by EM images of fibril disintegration sites, and likely accounts for “fragile 
fibrils” generating aligned arrays of short fibrils in many EM images (Figures 
3D, 4D, S2A and S3E). Tomogram analysis of fragmentation sites shows 
parallel protofibrils, chunks of protofibrils and globular oligomers attached to 
each other and to unnicked protofibrils. We speculate that through nicking of 
individual protofilaments/protofibrils, the chaperones weaken fibrils against 
tensile and shearing forces generated during negative stain EM preparation. 
Ultimately this nicking activity will generate protofilament and protofibril 
fragments that are short enough to dissociate from the fibrils and lead to 
complete fibril fragmentation. Nicking activity will substantially increase the 
number of new filament ends, facilitating chaperone-mediated, or even 
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spontaneous depolymerisation. This suggests depolymerisation becomes 
increasingly important during ongoing fibril disintegration since more free 
labile protofilaments and fibril ends are generated. This may explain why 
shortened fibrils (fractions 10-19 in sucrose density gradients; Figures 3A and 
S3B) are not detectably further fragmented, but instead are converted rapidly 
to α-Syn monomers. This disassembly reaction feature may allow limiting 
formation of shorter, more toxic α-Syn fragments and oligomers with amyloid 
seeding capacity. 
What is the molecular basis for the disassembly reaction? Using 
immunogold labeling, negative stain EM and electron-tomography we detect 
all three Hsc70, DNAJB1 and Apg2 components on fibril surfaces and provide 
3D-snapshots of the ongoing chaperone actions on fibrils. This is the first 
direct demonstration of association of Hsp110 with a substrate in vitro and 
also, the first visualization of a human disaggregase system bound to an 
amyloid substrate. Although each chaperone can separately associate with 
fibrils, disassembly requires the concerted action of all three components. 
Consistent with this, the range of differently sized globular structures that 
decorate fibrils in the presence of Hsc70/DNAJB1/Apg2 and ATP, includes 
larger structures, which most likely are dissociated α-Syn oligomers, not 
present when chaperones were added separately (Figures 3, 4 and S3E). 	  
Kinetic analysis of the concerted action of Hsc70/DNAJB1/Apg2 on α-
Syn fibrils leads to the model of fibril disassembly shown in Figure 7C. 
DNAJB1 rapidly associates with fibrils and accelerates subsequent 
recruitment and binding of Hsc70 by stimulating the ATPase activity of Hsc70. 
Binding of Apg2 then leads to rapid dissociation of Hsc70, DNAJB1 and Apg2 
itself. The Apg2-stimulated dissociation step of all three chaperones is critical 
for fibril disassembly. Specifically, the DNAJB1-mediated association of 
Hsc70 with fibrils followed by chaperone dissociation through spontaneous 
nucleotide exchange (in the absence of Apg2) is inefficient in triggering fibril 
breakage or depolymerization. We surmise the allosterically controlled, 
coordinated dissociation of all three chaperone components from the fibrils 
involves physical forces that generate the power stroke required for extraction 
of α-Syn molecules.   
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Several features of this functional chaperone cycle are consistent with 
the current model of the Hsp70 cycle (Mayer, 2013). Our results however, 
also reveal novel aspects, particularly relating to the role of the NEF. First, 
Apg2 promotes dissociation from the substrate of both Hsp70 and DNAJB1. 
This contradicts a previous “clamping and walking mechanism” proposed for 
Hsp110, Hsp70 and J-proteins acting on a substrate (Mattoo et al., 2013). 
That mechanism predicts that Hsp110 increases the lifetime of all three 
components on the surface of the aggregate during cooperative action, the 
opposite of what we find here. Second, Apg2 greatly accelerates the 
dissociation of Hsc70 and DNAJB1 from fibrils even at reactant 
concentrations which, in the absence of fibrils, only partially stimulate 
nucleotide exchange by Hsc70 (Figure S4I). Perhaps the local environment of 
the Hsc70/DNAJB1/Apg2 complex on the fibril surface, together with Apg2 
binding to the fibril, specifically targets Apg2 to Hsc70 for nucleotide 
exchange. Third, in contrast to Apg2, Bag1 hardly stimulates Hsc70 
dissociation from fibrils and fibril solubilization, even at concentrations where 
Bag1 and Apg2 NEF activities are comparable. This suggests either a NEF-
independent role of Apg2 in fibril disassembly or a finely tuned regulation of 
the NEF activity of Apg2 in concert with Hsc70, DNAJB1 and fibrils, to which 
Bag1 is insensitive.  
A salient finding is that deletion of the N- and C-terminal regions of α-
Syn (α-Syn30-110) protruding from the fibril axis (Vilar et al., 2008) completely 
abrogates fibril disassembly by Hsc70/DNAJB1/Apg2. Unexpectedly, 
chaperone association per se is not compromised. Instead the cooperation, at 
least between Hsc70 and DNAJB1, leading to the correct targeting and 
activation of Hsc70, is defective. We surmise the truncated α-Syn30-110 fibrils 
lack the local environment permitting the ordered association of the three 
chaperone components needed to generate the powerstroke driving 
disassembly. α-Syn30-110 fibrils may in addition have subtle structural 
differences to wt-α-Syn fibrils which confer increased resistance to 
disassembly activities. 
In conclusion our findings demonstrate efficient reversal of α-Syn fibril 
formation by a specific human Hsp70 chaperone network. This adds a new 
layer of complexity to the biology of amyloid protein fibrils. Definition of 
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parameters influencing the cellular α-Syn fibril disaggregase activity, including 
cooperation with other components of the chaperone network, should 
contribute to defining the pathophysiology of Parkinson´s disease and clarify 
apparent links to the mechanisms of aging. Understanding the biology and 
molecular mechanism of fibril disaggregation should also facilitate effective 
therapeutic interventions. Finally, determining the spectrum of amyloid 
proteins subject to Hsp70 network-dependent disaggregation should inform 
on the extent to which this disaggregase activity may be relevant for other 
amyloid protein-driven diseases. 
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Experimental procedures 
 
Fluorescent dyes and antibodies 
Alexa Fluor dyes were purchased from Life Technologies GmbH 
(Darmstadt, Germany). Mouse monoclonal antibodies against α-Syn (full 
length or truncation), Hsc70, GFP and rabbit polyclonal antibodies against 
DNAJB1 were purchased from Santa Cruz Biotechnology (Texas, USA), Acris 
Antibodies GmbH (Herford, Germany), Covance Inc. (Princeton, NJ, USA) 
and Enzo Life Sciences GmbH (Lörrach, Germany), respectively. Rabbit 
polyclonal antibodies against Hsc70 and Apg2 were produced by Charles 
River Laboratories (Sulzfeld, Germany). 
 
Protein expression and purification 
Human Hsc70, Apg2, Hsp105α, DNAJB1, Hdj2, Avi-tagged α-Syn were 
expressed in E. coli BL21 (DE3) with an N-terminal His6-Smt3-tag and 
purified by affinity chromatography and gel filtration as published earlier 
(Andreasson et al., 2008; Rampelt et al., 2012). After affinity purification the 
His-Sumo tag was cleaved off with SUMO-protease Ulp1. All the cleaved 
products were applied to fresh protino beads to remove His-Sumo and Ulp1. 
The flow though was collected and used for further purification. After cleavage 
and removal of the tag and Ulp1, DNAJB1 was further purified by cation 
exchange chromatography using a SP sepharose column, Hsc70 and Hdj2 
were further purified by Superdex 75 gel filtration in a buffer containing 50 mM 
Hepes pH 7.5, 150 mM KCl and 5% glycerol, and the remaining proteins were 
concentrated and frozen at -80°C. The gene encoding α-Syn was cloned into 
pTYB11 (intein/chitin-binding domain system; New England Biolabs) and 
purified following manufacture’s recommendations (Uversky et al., 2001), 
followed by further purification by gel filtration in a buffer containing 50 mM 
sodium phosphate, pH 7.5 and 100 mM NaCl. The α-Syn, Hsc70 and 
DNAJB1 point mutants were generated by PCR mutagenesis and standard 
cloning techniques and were verified by sequencing. His-Sumo-α-Syn 
fragment was obtained by fusion PCR and cloned into pTrc plasmid using 
NdeI and BamHI sites to generate a gene encoding His-Sumo-α-Syn-Avi-tag. 
pTrc-His-Sumo-α-Syn-Avi was co-overexpressed with the gene encoding 
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biotin-[acetyl-CoA-carboxylase] ligase BirA in E. coli to generate C-terminal 
biotin labeled α-Syn. Biotin was added to the culture medium at a final 
concentration of 40 mg/l. The C-terminal biotin labeled α-Syn was purified by 
affinity purification as described above. The purity of proteins was verified by 
SDS-PAGE and was generally >90%. 
 
Fibril formation 
To produce mature, long fibrils, 200 µM gel filtration purified α-Syn or 
α-Syn-S9C monomers were filtered through 0.2 µm filters and incubated in 
1.5 ml-microfuge tubes at 37℃ under orbital shaking (1000 rpm) at 37°C for 1 
week in a buffer containing 50 mM sodium phosphate pH 7.3, 100 mM NaCl 
and 0.05% sodium azide. EM imaging confirmed that our preparations 
contained mature fibrils and no amorphous aggregates or small beta-sheet 
aggregates. 
 
Fluorescent labeling of proteins and fibrils 
Purified Hsc70-T111C,C267A,C574A,C603A (100 µM), DNAJB1-
G194C (150 µM) or α-Syn-S9C monomer (85 µM) were incubated with a 
tenfold excess of Alexa Fluor® 488 C5 maleimide (Alexa488) or Alexa Fluor® 
594 C5 maleimide (Alexa594) at room temperature for 2 h (in excess of ATP 
for Hsc70 to avoid labeling the only remaining essential Cys17) followed by 
chromatography through a PD-10 desalting column (GE healthcare) to 
remove free dye. Labeling efficiency was monitored by nanodrop, using 
absorption at A280 (DNAJB1ε280 = 19035 M-1cm-1, Hsc70ε280 =33600 M-1cm-1, 
α-Synε280 = 5069 M-1cm-1) for protein concentration and absorption at A493 for 
Alexa488 (ε494 = 72000 M-1cm-1), A588 for Alexa594 (ε590 = 96000 M-1cm-1). 
The labeling efficiency was 100% as determined by protein and dye 
concentrations. The activity of labeled chaperones was comparable to that of 
the wild type proteins as measured by a luciferase disaggregation assay 
(Rampelt et al., 2012). For the labeling of α-Syn-S9C fibrils, 200 µM 
preformed α-Syn-S9C fibrils were incubated with a tenfold excess of Alexa488 
at room temperature for 2 h followed by centrifugation at 16,000 g for 15 min 
at 4℃ to remove free dye. Then the fibril pellet was washed three times with 
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50 mM Hepes-KOH pH 7.5, 150 mM KCl, 5 mM MgCl2 buffer to remove dye 
non covalently bound to fibrils. Fibrils were dissolved in 8 M guanidine 
chloride (GdnHCl) and the labeling efficiency was measured by nanodrop, 
using absorption at A280 (α-Synε280 = 5960 M-1cm-1) for protein concentration 
and absorption at A493 for Alexa488 (ε494 = 72000 M-1cm-1) concentration. The 
fibril labeling efficiency was normally around 70-90% as determined by protein 
and dye concentrations. 
 
Sedimentation assay (supernatant-pellet centrifugation) 
α-Syn fibrils were incubated in disaggregation buffer (50 mM Hepes-
KOH pH 7.5, 50 mM KCl, 5 mM MgCl2, 2 mM DTT supplemented with 2 mM 
ATP and ATP regeneration system (3 mM PEP, 20 ng/µL pyruvate kinase 
(PK)) and incubated with the indicated chaperones for different time intervals 
at 30°C. ATP, PEP and pyruvate kinase were omitted when necessary (-
ATP). The fibril-chaperone mixture was centrifuged at 16,000 g for 30 min at 
4°C. α-Syn levels in the supernatant or pellet were measured by western blot 
using α-Syn mouse monoclonal antibodies. Quantification of blots was done 
using ImageJ software.  
 
Fluorescence de-quenching assay and size exclusion chromatography  
Alexa488 labeled α-Syn-S9C monomers or preformed α-Syn-S9C 
fibrils (0.5 µM protomer) were incubated with 8 M guanidine chloride 
(GdnHCl) or different combinations of chaperones in the disaggregation buffer 
at 30°C. Disaggregation of labeled fibrils was determined by monitoring 
Alexa488 fluorescence intensity at 515 nm (excitation wavelength 488 nm) on 
a Perkin-Elmer LS 50B fluorescence spectrometer. Gel filtration of 
supernatant fractions from disassembled, fluorescently labeled α-Syn-S9C 
fibrils was performed using an analytical Superdex 75 10/300 GL column (GE 
Healthcare) at 25°C in 50 mM Hepes pH 7.5, 150 mM KCl, 5% glycerol. 
Eluted fractions were collected automatically and the fluorescence intensity of 
each fraction was measured by a Jasco fluorophotometer FP-6500. 
 
Negative stain EM 
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10 µl samples were applied to Formvar- and carbon-coated 100-mesh 
copper grids (Electron Microscopy Sciences) and incubated for 5 min. Grids 
were rinsed two or three times (for sucrose gradient samples) with 15 µl of de-
ionized water and negatively stained with 2% (w/v) uranyl acetate. Excess 
stain was removed by blotting and air drying. Samples were visualized with an 
80 kV Zeiss EM-900. Fibril length was measured manually using ImageJ 
software. 
 
Fibril fragmentation assay 
Biotin-labeled α-Syn-Avi monomers were mixed with wild type fibrils 
(200 µM monomer concentration, preformed for 7 days) at a ratio of 1:100 
and incubated for 4 days at 37°C. Heterofibrils (Avi-tag capped fibrils) were 
used to monitor fibril fragmentation according to the method of Inoue and 
Yoshida (Inoue and Yoshida, 2006). Briefly, heterofibrils were incubated with 
streptavidin-coated paramagnetic beads (Dynabeads® MyOne™ Streptavidin 
T1, Invitrogen/Life Technologies) at a ratio of fibrils volume:beads slurry of 
1:1. To remove excess and non-biotinylated fibrils the beads were washed at 
least 9 times with 50 mM Hepes-KOH pH 7.5, 50 mM KCl, 5 mM MgCl2, 2 mM 
DTT buffer containing 1% Triton X-100, followed by a single wash with 
disaggregation buffer. 5 µl aliquots of the bead-bound fibrils were incubated 
with chaperones in disaggregation buffer at 30°C for different time intervals. 
Disassembled wild type fibrils and soluble species were separated from bead-
tethered fibrils by immobilizing the paramagnetic beads in a magnetic field. 
 
Native polyacrylamide gel electrophoresis (Native PAGE) 
Protein samples were diluted into loading buffer without SDS or any 
reducing agents and then applied to a 10% Bis-Tris native gel. Gel 
electrophoresis was performed at 120 V for 2 h in 50 mM MOPS, 50 mM Tris, 
1 mM EDTA followed by western blot analysis. 
 
Sucrose gradient centrifugation 
α-Syn fibrils (10 µM monomer concentration) or monomers (10 µM) 
were incubated with or without individual or combinations of chaperones 
(10 µM Hsc70, 5 µM DNAJB1, 1 µM Apg2) in the disaggregation buffer at 
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30°C for the indicated time intervals. Then 350 µl of the reaction mixture was 
applied to 12 ml of a 15-60% sucrose gradient and centrifuged at 86,419 g 
(35,000 rpm) for 2.5 h at 4°C. After centrifugation, 500 µl fractions were 
manually removed with a 1 ml-pipette. 25 fractions were taken in total for each 
sample. The volume of the last fraction was adjusted to 500 µl. Each fraction 
was mixed by inverting 8-10 times and aliquots (100 µl) were taken for SDS 
PAGE and immunoblotting. Glycerol was omitted from the SDS-sample buffer. 
Relative amounts of α-Syn in each fraction after immunoblotting were 
quantified using imageJ for each time point. 
 
Fibril length measurement and α-Syn protomer calculation 
Fibrils incubated with or without chaperones for different time points 
were subjected to negative EM. EM pictures were randomly chosen and the 
lengths of 600 fibrils were measured using ImageJ software manually. 
Untreated fibrils have an average length of 1000 nm. Fibrils with lengths 
below 500 nm at each time point were grouped as short fibrils and the 
averaged length of short fibrils was calculated (254 nm). The structural model 
of α-Syn fibrils suggests one mature fibril consists of 4 protofilaments and the 
distance between two packed α-Syn protomers is 4.7 Å (Vilar et al., 2008).   
Based on the average length of the short fibrils and the protomer arrangement 
in the structural model of α-Syn fibrils, we estimate that 1 short fibril consists 
of, on average, 2000 α-Syn protomers. 
 
Immunogold labeling 
10 µl of sucrose gradient samples were incubated with grids for 5 min 
followed by blocking. Then the grids were incubated with rabbit anti DNAJB1, 
Hsc70 or Apg2 antibodies at 1:30, 1:2 and 1:1, respectively. Secondary 
immunogold-labelling was with goat anti-mouse or goat anti-rabbit IgG 
conjugated with 5-nm, 15-nm and 5-nm gold (Jackson ImmunoResearch 
Laboratories).  
 
Electron tomography 
Tilt series of negative stain samples of fibrils and chaperones were 
collected with SerialEM (Mastronarde, 2005) at 3° increments over a range of 
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±  60°, with a defocus of 1 to 2 µm. Images were recorded on a 200 kV Tecnai 
F20 EM (FEI) using a DE20 direct electron detector (Direct Electron, LP) at a 
nominal magnification of 13  000× (corresponding to a pixel size of 3 Å). 
Fiducial-free alignment of tilt images and tomogram reconstructions was 
carried out in IMOD (Kremer et al., 1996). For each combination of 
chaperones, 15 to 20 tomograms were reconstructed and analyzed. 
 
C. elegans strains and maintenance 
Wild-type (N2, Bristol) and transgenic animals were maintained using 
standard methods (Brenner, 1974). Nematodes were grown on NGM plates 
seeded with E. coli strain OP50 at 20°C. The strain OW40 zgIs15[unc-
54p::alpha-synuclein-WT::yfp]IV was obtained from the Caenorhabditis Gene 
Center (CGC).  
 
Isolation of detergent-insoluble α-Syn from C. elegans 
Nematodes expressing alpha-synuclein::YFP were age-synchronized 
by bleaching; gravid adult animals were treated with hypochloride bleaching 
solution (5,5 ml H2O; 2,5 ml 1M NaOH; 2 ml 5% hypochloride) and isolated 
eggs were hatched overnight in M9 buffer. 1000 synchronized L1 larvae were 
transferred onto each of 20 OP50 seeded 10 cm NGM plates and grown for 4 
days until they reached day two of adulthood. Animals were collected, washed 
in M9 buffer and suspended in lysis buffer (20 mM Tris, pH 7.5; 10 mM β-
mercaptoethanol; 0.5% Triton X-100) supplemented with complete protease 
inhibitor (Roche) before shock-freezing in liquid nitrogen. Proteins were 
extracted by adding 0.7 mm diameter Zirconia beads (BioSpec) and vortexing 
for 6 cycles of 60 s at max. and 20 s rest speed in a Vortex-Genie at 4°C, 
followed by further cell lysis on ice. The lysate was cleared from carcasses by 
centrifugation at 5000 rpm for 2 min at 4°C in a tabletop centrifuge. The lysate 
was mixed with 1% N-Lauroylsarcosine (Sarkosyl NL), followed by 
ultracentrifugation at 254,000 g for 2 h at 4°C. Pellet fractions were 
resuspended in 100 µl of 50 mM Hepes (pH 7.5), 50 mM KCl and 5 mM MgCl2 
buffer and washed twice to remove residual Sarkosyl NL. The final total 
protein concentration was around 500 µg/ml.   
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MTT assay 
SH-SY5Y cells were cultured in Dulbecco’s modified Eagle’s Medium 
F12 (Gibco) supplemented with 10% (v/v) fetal bovine serum at 37°C in 
5% CO2. Cells were plated at a density of 5×103 cells/well in 96-well plates 
(Costar) and incubated for 24 h at 37°C in 5% CO2. The medium was then 
replaced, and the fibril samples and controls (buffer alone or chaperone 
mixture alone) were incubated with cells for 24 h. Cell viability was measured 
using a CellTiter 96® Non-Radioactive Cell Proliferation Assay kit (Promega). 
Briefly, MTT (3-(4,5-Dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide) 
was added to cells and incubated for 4 h. The quantity of formazan generated 
(proportional to the number of viable cells) was measured by absorbance at 
570 nm using a plate reading spectrophotometer.  
 
Fluorescence anisotropy  
For steady state fluorescence anisotropy experiments purified 
DNAJB1-G194C and Hsc70-T111C,C267A,C574A,C603A were labeled with 
Alexa Fluor® 488–C5–maleimide or Alexa Fluor® 594–C5–maleimide. 0.1 µM 
labeled protein was incubated with increasing concentrations of preformed α-
Syn fibrils for 30 min at 25°C and changes in fluorescence anisotropy were 
determined using fluorophotometer FP-6500 (Jasco). Anisotropy values were 
converted into percentage of protein bound to fibrils at a given fibril 
concentration after corrections for changes in quantum yields. The one-site 
binding model was fitted to the data using GraphPad Prism® 6.0 (GraphPad 
software; San Diego, CA, USA). Association of labeled chaperones was 
monitored by the change of anisotropy with time at 25°C. Competition of 
alexa488-DNAJB1 with unlabeled DNAJB1 was measured by incubation of 
0.1 µM Alexa488-DNAJB1 with 3 µM α-Syn fibrils for 30 min at 30°C, followed 
by the addition of 50 µM unlabeled DNAJB1. Changes in fluorescence 
anisotropy with time were determined and fitted by a one-phase decay model 
using GraphPad Prism.  
For time-resolved anisotropy, the association kinetics of Hsc70 to α-
Syn fibrils was measured for different α-Syn fibril concentrations (based on 
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the monomer concentration) and all data globally fitted by the second order 
rate equation (Rutkowska et al., 2008) using GraphPad Prism. 
 
Förster resonance energy transfer (FRET) measurements 
For FRET experiments, 0.2 µM Alexa488-labeled preformed α-Syn-
S9C fibrils (calculated on the basis of the monomers) or monomers (donor) 
were mixed with 1 µM Alexa594-labeled DNAJB1 (acceptor) in 25 mM 
HEPES pH 7.5, 50 mM KCl and 5 mM MgCl2, and allowed to equilibrate for 30 
min at 30˚C before measuring the steady-state fluorescence. For competition 
experiments, 14-fold excess (relative to acceptor concentration) of unlabeled 
Hsc70, 2 mM ATP and 0.7 µM Apg2 was added sequentially and allowed to 
equilibrate for 20 min at 30˚C. Emission spectra were recorded on a Jasco 
FP6500 spectrofluorometer between 500 and 700 nm, at an excitation 
wavelength of 488 nm for Alexa488 (donor fluorophore). Increase in acceptor 
emission (at 611 nm for Alexa594) was quantified. For quantification, acceptor 
fluorescence of Alexa594-labeled DNAJB1 excited at 488 nm was subtracted. 
The Förster radius of the Alexa488-Alexa594 FRET pair is 60 Å (Spence and 
Johnson, 2010). All samples were measured at least in duplicate. FRET 
efficiency was calculated based on the increase of acceptor fluorescence and 
presented as a percentage of acceptor fluorescence in the absence of 
competitors.  
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Figure Legends 
 
Figure 1. ATP-dependent solubilization of α-Syn fibrils by joint action of 
Hsc70, DNAJB1 and Apg2. 
(A) Representative negative stain EM image of α-Syn fibrils assembled for 
one week at 37°C. (B) Solubilization of α-Syn fibrils detected by sedimentation 
assay. α-Syn fibrils (2 µM monomer concentration) were incubated in 
disaggregation buffer with individual or combinations of Hsc70, DNAJB1 and 
Apg2 (at 2 µM, 1µM, 0.2 µM respectively) in the presence or absence of ATP 
and ATP regeneration system for 4 h, subjected to centrifugation and 
solubilized α-Syn detected in the supernatant by immunoblotting. (C) Fibril 
solubilization kinetics. α-Syn fibrils (2 µM monomer) were incubated with 
different concentrations of Hsc70 (2 µM, 4 µM and 10 µM as indicated), 
DNAJB1 and Apg2. The molar ratio of Hsc70:DNAJB1:Apg2 was kept 
constant at 1:0.5:0.1. The percentage of disassembled soluble α-Syn species 
in the supernatant versus incubation time is plotted. The inset shows a zoom 
into the first 60 min. (D) Size exclusion chromatography of solubilized α-Syn 
fibrils. 4 µM Alexa488-α-Syn-S9C monomers (black, dashed line), soluble 
fractions of 8M GdnHCl denatured fibrils (red solid line) and fibrils treated for 4 
h with chaperones (Hsc70:DNAJB1:Apg2 = 2:1:0.2 µM blue and 10:5:1 µM 
black solid lines) were subjected to size exclusion chromatography. 
Fluorescence intensity of Alexa488 was monitored for fractions collected from 
each sample. The absorbance of 20 µM purified α-Syn-S9C monomers at 280 
nm was recorded as control. (E) Relative amounts of monomers and 
oligomers separated in (D) calculated from the fluorescence intensities. (F) 
Sedimentation assay. Sarkosyl-insoluble α-Syn-YFP aggregates isolated from 
C. elegans were incubated with disaggregation buffer control or 
Hsc70/DNAJB1/Apg2 (10 µM/5 µM/1 µM) for 4 h, subjected to centrifugation 
and solubilized α-Syn detected in the supernatant by immunoblotting using 
mouse monoclonal anti-GFP antibodies. (G) Sedimentation assay. α-Syn30-110 
fibrils (2 µM monomer) were incubated with indicated chaperones (2 µM 
Hsc70/1 µM DNAJB1/0.2 µM Apg2) for 4 h and then centrifuged at 16,000 g 
for 30 min at 4°C. Disassembled soluble α-Syn30-110 species in the 
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supernatant were detected by immunoblotting using α-Syn-60-95 mouse 
monoclonal antibodies. 
 
Figure 2. Hsc70/DNAJB1/Apg2 chaperones fragment α-Syn fibrils. 
(A) Time evolution of the length distribution of chaperone-treated fibrils. 2 µM 
α-Syn fibrils (monomer concentration) were incubated with 2 µM Hsc70, 1 µM 
DNAJB1 and 0.2 µM Apg2 for 2 to 1440 min as indicated. EM pictures were 
taken from negative stain samples for each time point. The lengths of 600 
fibrils were measured using ImageJ software and plotted as a histogram of 
fibril length distribution. (B) Flow diagram of the fibril fragmentation assay. 
Preformed α-Syn fibrils were incubated with in-vivo-biotinylated Avi-tagged α-
Syn to form heterofibrils (Avi-tag capped fibrils). Heterofibrils were bound to 
streptavidin-coated paramagnetic beads, treated with Hsc70/DNAJB1/Apg2 
and released material separated from bead-tethered fibrils in a magnetic field 
(method). (C) Characterization of α-Syn species released from magnetic 
beads upon chaperone treatment. Bead-tethered α-Syn heterofibrils (roughly 
2-10 µM) were incubated with 4 µM Hsc70, 2 µM DNAJB1 and 0.4 µM Apg2 
at 30℃ for 2 h or 4 h in the absence or presence of 2 mM ATP. α-Syn levels 
in the bead-separated supernatant were measured by immunoblotting. (D) EM 
images of untreated heterofibrils and α-Syn species released from the beads 
by chaperone treatment. Scale bar, 250 nm.  
 
Figure 3. Combined Hsc70/DNAJB1/Apg2 activity efficiently 
disassembles α-Syn fibrils into monomers and short fibrils. 
(A) Analysis of fibril disassembly reactions by sucrose gradient centrifugation. 
10 µM α-Syn monomers, fibrils or fibrils incubated with 10 µM Hsc70, 5 µM 
DNAJB1, 1 µM Apg2 for 4 h were subjected to sucrose gradient 
centrifugation. Distributions of α-Syn or chaperone proteins in each fraction 
(total 25 fractions) were detected by immunoblotting using specific antibodies 
as indicated to the right. Fractions 1 to 4 (group I), 10 to 19 (group II) and 25 
(group III) represent monomers, short fibrils, and unfragmented fibrils, 
respectively. (B) Representative EM images of α-Syn species of different 
sucrose gradient fractions (F1, F11, F15, F25) from chaperone-treated fibrils 
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shown in (A). Scale bar, 1 µm. (C) Time course of a fibril disassembly reaction 
separated by sucrose gradient centrifugation. Relative amounts of α-Syn in 
each of the three groups in (A) were quantified by immunoblotting for every 
time point. (D) Captured fragmentation events. Left panel, untreated α-Syn 
fibrils from fraction 25 of the sucrose gradient centrifugation. Right panel, α-
Syn fibrils in sucrose gradient fraction 15 separated from disassembly 
reaction containing the full chaperone system. Aligned short separate fibrils 
decorated with globular structures (right, white arrows). Scale bar, 50 nm. (E) 
Immunogold labeling of Hsc70 (15 nm gold), DNAJB1 (5 nm gold) and Apg2 
(5 nm gold) in sucrose gradient fraction 15 separated disassembly reaction 
containing the full chaperone system. Scale bar, 100 nm. 
 
Figure 4. Chaperone interaction with α-Syn fibrils and fibril 
disintegration visualised by electron tomography.  
(A) Section through a tomogram of α-Syn fibrils, averaged over 15 z-slices. 
The area boxed in red is enlarged on the right. (B) Schematic diagram 
showing section planes through the tomogram, with 1 and 2 indicating upper 
and central slices, respectively. (C-D) Section through a tomogram of α-
Syn fibrils binding the full chaperone complement (C) and fragmented fibrils 
(D) averaged over 15 z-slices.  Right, enlarged views of the boxed region, 
shown for the upper and central section planes of chaperone decorated fibrils 
(C) or fragmented fibrils with original mature fibril (yellow line), parallel 
protofibrils (white lines) and nicked protofibrils (white arrows) (D).   
(E) Sections through the tomograms of α-Syn fibrils alone, with each 
chaperone separately, and with Hsc70/DNAJB1. Scale bars, 20 nm. 
 
Figure 5. DNAJB1 accelerates Hsc70 loading onto α-Syn fibrils and Apg2 
triggers release of Hsc70 and DNAJB1. 
(A) Steady-state fluorescence anisotropy changes upon addition of α-Syn 
fibrils to Alexa488-DNAJB1 or Alexa488-Hsc70 (0.1 µM). Anisotropy values 
were converted into percentage of protein bound to fibrils at a given fibril 
concentration (monomer concentration) after corrections for changes in 
quantum yield. Binding curves of Alexa488-DNAJB1 (left), Alexa488-Hsc70 in 
the absence (middle) or presence of 0.05 µM DNAJB1 (right) were fitted by a 
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one-site binding model using GraphPad Prism. (B) Hsc70, Apg2 and ATP 
lead to release of DNAJB1 from fibrils. Fluorescence emission spectra of 
Alexa488-α-Syn-S9C fibrils (green), Alexa594-DNAJB1 (red), and mixtures of 
both in the absence (black) and presence of Hsc70 (brown), Hsc70+ATP 
(purple), and Hsc70+ATP+Apg2 (blue). The sum of the individual spectra of 
Alexa488-α-Syn-S9C-fibrils and Alexa594-DNAJB1-G194C is the dashed 
orange line. The concentrations for Alexa488-α-Syn-S9C-fibrils, Alexa594-
DNAJB1, Hsc70, Apg2 and ATP are 0.2 µM, 1 µM, 14 µM, 0.7 µM and 2 mM, 
respectively. Fluorescence excitation at 488 nm, emission detected at 611nm 
with a 20 nm slit. (C) Relative acceptor fluorescence in the presence of 
different chaperones (minimum 3 measurements) shown in (B). Error bar = 
standard error of the mean. (D) Apg2 leads to rapid release of Hsc70. 
Fluorescence anisotropy traces of Alexa488-Hsc70 (0.1 µM) in the presence 
of DNAJB1 (0.05 µM) and α-Syn fibrils (0.6 µM). In separate reactions Apg2 
or Bag1 was added to the reactions at time point 300 s as indicated. (E), Fibril 
disassembly activity in the presence of Hsc70 (2 µM) and DNAJB1 (1 µM) and 
absence or presence of different nucleotide exchange factors as indicated.  
 
Figure 6. Inability of Hsc70 chaperone system to disassemble α-Syn30-110 
fibrils. 
(A) Representative negative stain EM image of α-Syn30-110 fibrils assembled 
for one week at 37°C. (B) Sedimentation assay. α-Syn30-110 fibrils (2 
µM monomer) were incubated with indicated chaperones (2 µM Hsc70/1 µM 
DNAJB1/0.2 µM Apg2) for 4 h and then centrifuged at 16,000 g for 30 min at 
4°C. Disassembled soluble α-Syn30-110 species in the supernatant were 
detected by immunoblotting using α-Syn-60-95 mouse monoclonal antibodies. 
(C). Anisotropy changes upon binding of Alexa488-Hsc70-T111C (0.1 µM) to 
α-Syn or α-Syn30-110 fibrils (3 µM) in the absence or presence of DNAJB1 
(0.05 µM) and dissociation of fibril-bound Alexa488-Hsc70-T111C triggered 
by Apg2 (0.45 µM). Dissociation of Hsc70 from fibrils was triggered by adding 
Apg2 at 900 sec as indicated. 
 
Figure 7. Cell toxicity of disassembled α-Syn species and model for 
chaperone action in fibril disassembly. 
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(A) α-Syn fibrils or monomers (2 µM protomers) were incubated with or 
without Hsc70 (2 µM), DNAJB1 (1 µM) and Apg2 (0.1 µM) for 2 h. Total 
mixture (T, final concentration of α-Syn 0.2 µM) or supernatant after 
centrifugation at 16,000 g for 30 min (S, final concentration of α-Syn 0.04 µM) 
was added to culture medium of SH-SY5Y cells for 24 h. Cell toxicity was 
measured by MTT reduction. (B) α-Syn species released from bead-tethered 
fibrils (T) in the absence of chaperones (blue bars) or presence of 
Hsc70/DNAJB1/Apg2 (red bars) and the soluble (S) or pellet (P) fractions of 
these reactions were added to culture medium of SH-SY5Y cells for 24 h. Cell 
toxicity was measured by MTT reduction. The final concentration of α-Syn 
was 0.01 µM (protomer) in the total chaperone-released fraction and 
0.0033 µM in the supernatant of this reaction. Final concentration of Hsc70 in 
the medium was 0.25 µM. (C) Model for chaperone-mediated disassembly of 
α-Syn fibrils. Individual DNAJB1 (blue), Hsc70 (purple) and Apg2 (green) 
chaperone components interact with α-Syn fibrils (yellow). In the presence of 
the complete Hsc70/DNAJB1/Apg2 system, however, DNAJB1 binds rapidly 
along the entire length of fibrils (step 1) and recruits Hsc70 in the ATP (T) 
state, which Hsc70 hydrolyzes, converting Hsc70 to the ADP (D) state, 
forming DNAJB1-Hsc70 complexes on the fibril surface (step 2). The 
DNAJB1-Hsc70 mediated reaction on its own confers only low basal fibril 
disassembly activity. Binding of the NEF Apg2 to the DNAJB1-Hsc70 complex 
catalyzes ADP release from Hsc70 (step 3), followed by rebinding of ATP to 
Hsc70. This promotes rapid release of Hsc70, DNAJB1 and Apg2 from the 
fibril (step 4). Step 4 is considered to involve structural changes in the 
chaperone complex, eliciting a power stroke that liberates α-Syn molecules 
from the internal sites and ends of fibrils. Iterative cycles of fibril binding and 
release successively introduce nicks into protofilaments and protofibrils, 
progressively disintegrating fibrils until these breaks apart (fragmentation). 
This process increasingly generates free fibril ends which are preferred sites 
for depolymerisation, liberating monomeric α-Syn.  
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